The HCPLive rheumatoid arthritis page is a comprehensive resource for clinical news and insights on arthritis. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for RA, and more.
May 31st 2023
An analysis of patient data from Sweden and Norway detail the impact of achieving remission with methotrexate or TNF inhibitors on risk of acute coronary syndrome in patients with rheumatoid arthritis.
Impact of Health Literacy in Disease Activity, Medications in Rheumatoid ArthritisApril 28th 2023
Patients with “good health literacy” had significantly lower disease activity over time than those with “several health literacy limitations,” adjusting for age, gender and education level.
DAS28-ESR Scores Higher in Female Patients With Rheumatoid Arthritis in RemissionApril 21st 2023
Women with rheumatoid arthritis (RA) in remission exhibited higher values of Disease Activity Score-28 for Rheumatoid Arthritis with erythrocyte sedimentation rate (DAS28-ESR) compared with men.
Addressing Social Determinants to Achieve Equity in Care for Patients with Rheumatoid ArthritisMarch 3rd 2023
Disease activity and burden were higher in patients with rheumatoid arthritis with Medicaid or Medicare coverage, African American patients, and those residing in Southern regions.
FDA Approves Sarilumab as First, Only Biologic Treatment for Polymyalgia RheumaticaMarch 1st 2023
The approval was based on positive results from the Phase 3 SAPHYR trial, which showed that nearly 3 times more patients achieved sustained remission with sarilumab when compared with placebo.
Multidisciplinary Lifestyle Program Decreased Disease Activity in Patients With Rheumatoid ArthritisFebruary 3rd 2023
“Reversing and preventing adverse lifestyle factors could potentially reduce the incidence and burden of rheumatoid arthritis, as well as alleviate its comorbidities,” investigators hypothesized.
Rheumatology Month in Review: January 2023January 29th 2023
The January 2023 rheumatology month in review highlights a recent study that indicated an increased risk of hospitalization and death among patients with gout and COVID-19, the expansion of research evaluating adalimumab biosimilars, and trends in fibromyalgia.
Despite Research, Utility of Calprotectin as Biomarker in Rheumatoid Arthritis Still UnclearJanuary 26th 2023
A meta-analysis with data from more than 30 published articles provides an overview of associations between calprotectin levels and disease activity, treatment response, and inflammation among patients with rheumatoid arthritis.
Greater Self-Reported Disability Linked to Worse Disease Activity, Physical Function in Patients With Rheumatoid ArthritisJanuary 26th 2023
"Changes in the Health Assessment Questionnaire (HAQ) seem to be associated with changes in objectively assessed strength and physical function, suggesting HAQ captures the patient impact of sarcopenia-related disability,” investigators noted.
SmartClic/ClicWise Autoinjector Could Ease Burden of Self-Administered Injections in Rheumatoid ArthritisJanuary 26th 2023
A study of health care professionals' opinions of the ease of use and utility of the SmartClic/ClicWise autoinjector provides insight into the use of the device for patients with rheumatic conditions.
Patients With Inflammatory Arthritis Feel Positive Toward Most Vaccinations
General practitioners and rheumatologists were viewed as sources of information that led to positive views toward vaccinations, while internet chatrooms, social media, and mainstream media were seen as sources of information that led to negative views.
Targeting the MK2 Pathway Reduces Tachyphylaxis Related to Rheumatoid Arthritis TherapyJanuary 24th 2023
P38 mitogen-activated protein kinase (p38 MAPK) inhibitors have been a focal point for inflammatory diseases but the lack of efficacy in treating rheumatoid arthritis led to examination of the MK2 pathway.